A Phase 2b Randomized Controlled Trial of Presatovir, an...

The Journal of Heart and Lung Transplantation 2018 / 04 Vol. 37; Iss. 4

A Phase 2b Randomized Controlled Trial of Presatovir, an Oral RSV Fusion Inhibitor, for the Treatment of Respiratory Syncytial Virus (RSV) in Lung Transplant (LT) Recipients

Gottlieb, J., Torres, F., Haddad, T., Dhillon, G., Dilling, D.F., Knoop, C., Rampolla, R., Walia, R., Ahya, V., Kessler, R., Mason, D.P., Budev, M., Neurohr, C., Glanville, A.R., Jordan, R., Porter, D
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Volume:
37
Language:
english
Journal:
The Journal of Heart and Lung Transplantation
DOI:
10.1016/j.healun.2018.01.375
Date:
April, 2018
File:
PDF, 170 KB
english, 2018
Conversion to is in progress
Conversion to is failed